Profile data is unavailable for this security.
About the company
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
- Revenue in CAD (TTM)29.82k
- Net income in CAD-11.70m
- Incorporated2008
- Employees25.00
- LocationZentek Ltd24 Corporate CtGUELPH N1G 5G5CanadaCAN
- Phone+1 (705) 618-0900
- Fax+1 (705) 618-0900
- Websitehttps://www.zentek.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZYUS Life Sciences Corp | 387.00k | -41.25m | 73.78m | 2.00 | -- | 3.67 | -- | 190.64 | -0.5751 | -0.5751 | 0.0057 | 0.2833 | 0.0165 | -- | 0.7911 | -- | -175.44 | -57.88 | -242.41 | -71.19 | 46.25 | -16.16 | -10,658.40 | -10,367.37 | 0.315 | -7.99 | 0.3295 | -- | 17.79 | 213.99 | -72.73 | -- | -- | -- |
Arch Biopartners Inc | 1.50m | -2.14m | 99.74m | -- | -- | -- | -- | 66.49 | -0.0341 | -0.0341 | 0.024 | -0.1025 | 0.5472 | -- | 0.6897 | -- | -78.01 | -214.82 | -- | -- | -- | -- | -142.55 | -180.45 | -- | -4.06 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
Oncolytics Biotech Inc | 0.00 | -28.21m | 112.98m | 29.00 | -- | 4.83 | -- | -- | -0.4027 | -0.4027 | 0.00 | 0.3046 | 0.00 | -- | -- | -- | -80.51 | -81.99 | -88.84 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0468 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
Zentek Ltd | 29.82k | -11.70m | 136.62m | 25.00 | -- | 6.75 | -- | 4,581.54 | -0.1167 | -0.1167 | 0.0003 | 0.2001 | 0.0011 | 0.155 | 0.0689 | 1,192.80 | -41.89 | -47.65 | -45.33 | -51.12 | -1,010.23 | -- | -39,248.79 | -13,980.33 | 2.65 | -- | 0.058 | -- | -59.07 | -- | 18.80 | -- | -19.38 | -- |
Eupraxia Pharmaceuticals Inc | 0.00 | -42.38m | 138.75m | 29.00 | -- | 5.12 | -- | -- | -1.68 | -1.68 | 0.00 | 0.7599 | 0.00 | -- | -- | 0.00 | -122.29 | -127.84 | -185.74 | -935.99 | -- | -- | -- | -- | -- | -85.63 | 0.3455 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
Medicenna Therapeutics Corp | 0.00 | -25.47m | 157.66m | 16.00 | -- | 27.63 | -- | -- | -0.3657 | -0.3657 | 0.00 | 0.0745 | 0.00 | -- | -- | 0.00 | -91.64 | -54.93 | -104.12 | -60.91 | -- | -- | -- | -- | -- | -2.75 | 0.00 | -- | -- | -- | -153.44 | -- | -- | -- |
NervGen Pharma Corp | 0.00 | -20.02m | 196.76m | 10.00 | -- | 10.40 | -- | -- | -0.3363 | -0.3363 | 0.00 | 0.2692 | 0.00 | -- | -- | -- | -78.68 | -121.15 | -138.24 | -180.20 | -- | -- | -- | -- | -- | -9.07 | 0.0092 | -- | -- | -- | -8.01 | -- | 2.20 | -- |